| 716118 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma |
2021-07-15 |
10.3389/fonc.2021.689593 |
Peng Hao, Chen Bin-bin, Wang Xiao-hui, Mo Yun-Xian, Han Fei |
| 716117 |
FRONTIERS IN ONCOLOGY |
Construction of Novel lncRNA–miRNA–mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma |
2021-07-15 |
10.3389/fonc.2021.626663 |
Zhan Tian, Gao Xiang, Wang Guoguang, Li Fan, Shen Jian, Lu Chen, Xu Lei, Li Yuan, Zhang Jianping |
| 716116 |
FRONTIERS IN ONCOLOGY |
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases |
2021-07-15 |
10.3389/fonc.2021.628927 |
Yuan Jiangyuan, Li Ying, Liu Xuanhui, Nie Meng, Jiang Weiwei, Fan Yibing, Xiang Tangtang, Wang Hanhua, Quan Wei, Gao Chuang, Huang Jinghao, An Shuo, Ru Yongxin, Zhou Qiufan, Zhang Jianning, Jiang Rongcai |
| 716115 |
FRONTIERS IN ONCOLOGY |
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies |
2021-07-15 |
10.3389/fonc.2021.719091 |
Ratnam Nivedita M., Sonnemann Heather M., Frederico Stephen C., Chen Huanwen, Hutchinson Marsha-Kay N. D., Dowdy Tyrone, Reid Caitlin M., Jung Jinkyu, Zhang Wei, Song Hua, Zhang Meili, Davis Dionne, Larion Mioara, Giles Amber J., Gilbert Mark R. |
| 716114 |
FRONTIERS IN ONCOLOGY |
Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications |
2021-07-15 |
10.3389/fonc.2021.611218 |
Maiuri Francesco, Mariniello Giuseppe, de Divitiis Oreste, Esposito Felice, Guadagno Elia, Teodonno Giuseppe, Barbato Marcello, Del Basso De Caro Marialaura |
| 716113 |
FRONTIERS IN ONCOLOGY |
Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma |
2021-07-15 |
10.3389/fonc.2021.650891 |
Cui Heyang, Weng Yongjia, Ding Ning, Cheng Chen, Wang Longlong, Zhou Yong, Zhang Ling, Cui Yongping, Zhang Weimin |
| 716112 |
FRONTIERS IN ONCOLOGY |
Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio–EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy |
2021-07-15 |
10.3389/fonc.2021.583283 |
Huang Zhang-Zan, Wen Wen, Hua Xin, Song Chen-Ge, Bi Xi-Wen, Huang Jia-Jia, Xia Wen, Yuan Zhong-Yu |
| 716111 |
FRONTIERS IN ONCOLOGY |
Advanced Deep Learning Approach to Automatically Segment Malignant Tumors and Ablation Zone in the Liver With Contrast-Enhanced CT |
2021-07-15 |
10.3389/fonc.2021.669437 |
He Kan, Liu Xiaoming, Shahzad Rahil, Reimer Robert, Thiele Frank, Niehoff Julius, Wybranski Christian, Bunck Alexander C., Zhang Huimao, Perkuhn Michael |
| 716110 |
FRONTIERS IN ONCOLOGY |
Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC) |
2021-07-15 |
10.3389/fonc.2021.677926 |
Zhao Pin, Malik Samiullah, Xing Shaojun |
| 716109 |
FRONTIERS IN ONCOLOGY |
Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer |
2021-07-15 |
10.3389/fonc.2021.724655 |
Yu Dingye, Yang Xiao, Lin Jianwei, Cao Zichao, Lu Chenghao, Yang Zheyu, Zheng Minhua, Pan Ruijun, Cai Wei |
